Breaking a Duopoly: Ukraine’s New Approach to Pharmaceutical Distribution
The Problem Ukraine’s decade-long selective distribution practices in the pharmaceutical market are currently facing unparalleled antitrust scrutiny. This follows the introduction of controversial new regulation that reflect a growing trend: substituting timely, targeted market failure interventions and adequate enforcement with legislative restrictions that are economically unsound and severely undermine decades of the established commercial strategies….